2m 2m 2m 2m 2m 2m 2m
MINK THERAP (INKT)
NASDAQ
$12.54-$0.22 (-1.73%)
Price as of Jun 03, 2026 7:57 PM EDT- $60.8MMarket Cap
- 67.74%1-Year Change
- BiotechnologyIndustry
MINK THERAP (INKT)
$12.54-$0.22 (-1.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 180,246 +4.45% | 172,568 -62.75% | 463,256 +82.87% | 253,323 -63.29% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 180,246 +4.45% | 172,568 -62.75% | 463,256 +82.87% | 253,323 -63.29% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -5.8M -9.13% | -6.3M -59.10% | -15.5M -32.99% | -23.1M +65.51% | |
Depreciation and Amortization Expense | 181,745 -15.64% | 215,437 +5.29% | 204,617 +68.06% | 121,749 +56.17% | |
Total Operating Expenses | 6.7M +55.99% | 4.3M -41.94% | 7.4M -5.14% | 7.8M +68.84% | |
Operating Profit | -12.6M +11.99% | -11.3M -50.75% | -22.9M -25.94% | -30.9M +9.14% | |
Interest Income | 290,000 +9.43% | 265,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | -110,000 +18.28% | -93,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 180,000 +4.65% | 172,000 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -32,370 -109.78% | 330,915 +3,309,250.00% | -10 -100.00% | 2.7M +1,118.79% | |
Income before Taxes | -12.6M +11.99% | -11.3M -50.75% | -22.9M -25.94% | -30.9M +9.14% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -12.5M +15.85% | -10.8M -51.98% | -22.5M -19.77% | -28.0M -7.35% | |
Net Income from Continuing Operations Applicable to Common | -12.5M +15.85% | -10.8M -51.98% | -22.5M -19.77% | -28.0M -7.35% | |
Basic EPS and Net Income | -2.93 +2.45% | -2.86 +340.00% | -0.65 -21.69% | -0.83 -28.45% | |
Diluted EPS and Net Income | -2.93 +2.45% | -2.86 +340.00% | -0.65 -21.69% | -0.83 -28.45% | |
Basic Weighted Average Shares | 4.3M +13.18% | 3.8M -89.02% | 34.4M +2.04% | 33.7M +29.38% | |
Diluted Weighted Average Shares | 4.3M +13.18% | 3.8M -89.02% | 34.4M +2.04% | 33.7M +29.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 13.4M +191.90% | 4.6M +35.93% | 3.4M -82.85% | 19.6M -49.51% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 13.4M +191.90% | 4.6M +35.93% | 3.4M -82.85% | 19.6M -49.51% | |
Total Current Assets | 13.8M +177.63% | 5.0M +38.62% | 3.6M -82.37% | 20.4M -48.52% | |
Accumulated Depreciation | 612,245 +16.70% | 524,639 +5.85% | 495,638 +74.72% | 283,682 +68.25% | |
Property and Plant and Equipment and Net | 390,869 -46.67% | 732,929 -23.17% | 953,977 -10.59% | 1.1M +75.89% | |
Total Long-Term Assets | 390,869 -46.67% | 732,929 -23.17% | 953,977 -10.59% | 1.1M +75.89% | |
Total Assets | 14.2M +148.90% | 5.7M +25.67% | 4.6M -78.80% | 21.5M -46.64% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 5.9M 0.00% | |
Total Current Liabilities | 13.0M +87.24% | 7.0M -38.96% | 11.4M -10.10% | 12.7M -22.97% | |
Total Long-Term Debt | 5.0M 0.00% | 5.0M 0.00% | 5.0M -44.94% | 9.1M -79.28% | |
Total Long-Term Liabilities | N/A N/A | 0 -100.00% | 48,072 -55.69% | 108,500 -71.68% | |
Total Liabilities | 13.0M +87.24% | 7.0M -38.96% | 11.4M -10.10% | 12.7M -22.97% | |
Retained Earnings | -156.7M +8.67% | -144.2M +8.08% | -133.4M +20.24% | -110.9M +33.75% | |
Total Stockholders Equity | -14.2M -27.36% | -19.6M +8.48% | -18.1M +4,399.21% | -401,303 -101.69% | |
Total Shares Outstanding | 4.7M +18.75% | 4.0M -88.55% | 34.6M +2.19% | 33.9M +1.13% | |
Cash Flow | |||||
Cash from Operating Activities | -5.9M -37.99% | -9.6M -39.38% | -15.8M -16.45% | -18.9M +47.09% | |
Capital Expenditures | N/A N/A | 73,561 0.00% | 73,561 -70.58% | 250,046 +0.43% | |
Cash from Investing Activities | N/A N/A | -73,561 0.00% | -73,561 -70.58% | -250,046 +0.43% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 14.7M +36.06% | 10.8M +2,757.34% | -407,173 +161.68% | -155,599 -100.32% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -7,013.82% +7.22% | -6,541.35% +32.21% | -4,947.83% -59.50% | -12,217.32% N/A | |
Return on Assets | -125.20% -40.37% | -209.96% +21.65% | -172.59% +90.26% | -90.71% N/A | |
Return on Equity | 73.90% +28.97% | 57.30% -76.45% | 243.36% +201.61% | -239.50% N/A | |
Revenue Growth | 4.45% +107.09% | -62.75% -175.72% | 82.87% +230.95% | -63.29% N/A | |
Current Ratio | 1.06 +48.28% | 0.72 +127.09% | 0.32 -80.38% | 1.61 N/A | |
Cash Ratio | 1.03 +55.88% | 0.66 +122.72% | 0.30 -80.93% | 1.55 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | -37.44 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.70 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow